Source: iQoncept / Shutterstock
Biofrontera (NASDAQ:BFRI) has just unveiled its fourth-quarter 2023 outcomes.
- The reported earnings per share surged to $1.65, cruising past the estimated EPS of -$1.19, sending a jubilant shockwave through the market.
- On the revenue front, Biofrontera amassed $10.60 million; a result slightly short of the predicted $11.52 million, hinting at a minor hiccup.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/bfri-stock-earnings-biofrontera-for-q4-of-2023/.
©2024 InvestorPlace Media, LLC







